SUBSCRIBE
SUBSCRIBE

Cassava Sciences Inc.

NEWS
Deals
Top 2003 Stories From The BioSpace NewsBeat
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Cassava Reports Q3 2025 Financials Results and Provides Business Update
November 13, 2025
 · 
13 min read
Press Releases
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
October 23, 2025
 · 
6 min read
Press Releases
Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
August 25, 2025
 · 
1 min read
Press Releases
Cassava Reports Q2 2025 Financials Results and Provides Business Update
August 15, 2025
 · 
13 min read
Press Releases
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer
August 8, 2025
 · 
6 min read
Press Releases
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy
August 5, 2025
 · 
10 min read
Press Releases
Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting
July 1, 2025
 · 
8 min read
Press Releases
Cassava Reports Q1 2025 Financials Results, Provides Business Update
May 8, 2025
 · 
9 min read
Press Releases
Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC
May 2, 2025
 · 
6 min read
Press Releases
Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development
April 22, 2025
 · 
6 min read
Load More